BCR	B-cell receptor
BTK	Bruton’s kinase
BTKIs	BTK inhibitors
CLL	lymphocytic leukemia
CIA	collagen-induced arthritis
DPPY	diphenylaminopyrimidine
EGFR	epidermal growth factor receptor
FAK	focal adgesion kinase
FBDD	fragment-based drug discovery
cGVHD	chronic graft versus host disease
MZL	marginal zone lymphoma
MCL	mantle cell lymphoma
MS	multiple scherosis
NSCLC	non-small cell lung cancer
PMDA	Pharmaceuticals and Medical Devices Agency
PH	pleckstrin homology domain
Pho-DPYYs	diphenylpyrimidine derivatives
PLCγ2	phospholipase γ2
PK	pharmacokinetic
PROTAC	proteolysis-targeting chimera compounds
PRR	proline-rich regions
RA	rheumatoid arthritis
RMS	Relapsing Multiple Sclerosis
ROS	reactive oxygen species
SBD	structure-based design
SLL	small lymphocytic lymphoma
SH2/SH3	Src homology 2/3 domain
SLE	Systemic Lupus Erythematosus
TK	tyrosine kinases
WM	Waldenström’s macroglobulinemia
WT	wild type